These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 22612327)

  • 1. Treatment of whole blood with riboflavin plus ultraviolet light, an alternative to gamma irradiation in the prevention of transfusion-associated graft-versus-host disease?
    Fast LD; Nevola M; Tavares J; Reddy HL; Goodrich RP; Marschner S
    Transfusion; 2013 Feb; 53(2):373-81. PubMed ID: 22612327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developments in the prevention of transfusion-associated graft-versus-host disease.
    Fast LD
    Br J Haematol; 2012 Sep; 158(5):563-8. PubMed ID: 22734439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogen reduction by ultraviolet C light effectively inactivates human white blood cells in platelet products.
    Pohler P; Müller M; Winkler C; Schaudien D; Sewald K; Müller TH; Seltsam A
    Transfusion; 2015 Feb; 55(2):337-47. PubMed ID: 25134439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mirasol PRT treatment of donor white blood cells prevents the development of xenogeneic graft-versus-host disease in Rag2-/-gamma c-/- double knockout mice.
    Fast LD; DiLeone G; Cardarelli G; Li J; Goodrich R
    Transfusion; 2006 Sep; 46(9):1553-60. PubMed ID: 16965583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. White blood cell inactivation after treatment with riboflavin and ultraviolet light.
    Marschner S; Fast LD; Baldwin WM; Slichter SJ; Goodrich RP
    Transfusion; 2010 Nov; 50(11):2489-98. PubMed ID: 20529002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a riboflavin and ultraviolet light-based device to treat whole blood.
    Reddy HL; Doane SK; Keil SD; Marschner S; Goodrich RP
    Transfusion; 2013 Jan; 53 Suppl 1():131S-136S. PubMed ID: 23301965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photochemical inactivation of lymphocytes by riboflavin with visible light for TA-GVHD prevention.
    Mo Q; Huang Y; Wang L; Cheng Z; Wu X; Jia Y; Wang X; Zhang B
    J Photochem Photobiol B; 2017 Sep; 174():276-283. PubMed ID: 28806684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phytohemagglutinin-activated human T cells induce lethal graft-versus-host disease in cyclophosphamide and anti-CD122 conditioned NOD/SCID mice.
    Hu Y; Gu Y; Cui Q; Fu H; Sheng L; Wu K; Liu L; Fu S; Yu X; Huang H
    Ann Hematol; 2012 Nov; 91(11):1803-12. PubMed ID: 22699803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amotosalen/UVA treatment inactivates T cells more effectively than the recommended gamma dose for prevention of transfusion-associated graft-versus-host disease.
    Castro G; Merkel PA; Giclas HE; Gibula A; Andersen GE; Corash LM; Lin JS; Green J; Knight V; Stassinopoulos A
    Transfusion; 2018 Jun; 58(6):1506-1515. PubMed ID: 29607502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of transfusion-associated graft-versus-host disease with pathogen-reduced platelets with amotosalen and ultraviolet A light: a review.
    Cid J
    Vox Sang; 2017 Oct; 112(7):607-613. PubMed ID: 28833219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogen-reduction systems for blood components: the current position and future trends.
    Seghatchian J; de Sousa G
    Transfus Apher Sci; 2006 Dec; 35(3):189-96. PubMed ID: 17110168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivation of human white blood cells in platelet products after pathogen reduction technology treatment in comparison to gamma irradiation.
    Fast LD; DiLeone G; Marschner S
    Transfusion; 2011 Jul; 51(7):1397-404. PubMed ID: 21155832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Irradiation eradication and pathogen reduction. Ceasing cesium irradiation of blood products.
    Mintz PD; Wehrli G
    Bone Marrow Transplant; 2009 Aug; 44(4):205-11. PubMed ID: 19617907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
    Strober S
    Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. X-ray irradiation effectively inactivated lymphocytes in transfusion in vivo monitored by the bioluminescence transfusion-associated graft-versus-host disease model.
    Peng D; Bai W; Zhang C; Chang X; Ma P; Wang X; Sun S; Zhan L
    Vox Sang; 2024 Mar; 119(3):181-192. PubMed ID: 38226529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogen reduction with riboflavin and ultraviolet light induces a quasi-apoptotic state in blood leukocytes.
    Tran JQ; Muench MO; Heitman JW; Jackman RP
    Transfusion; 2019 Nov; 59(11):3501-3510. PubMed ID: 31599981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune modulation and lack of alloimmunization following transfusion with pathogen-reduced platelets in mice.
    Jackman RP; Muench MO; Heitman JW; Inglis HC; Law JP; Marschner S; Goodrich RP; Norris PJ
    Transfusion; 2013 Nov; 53(11):2697-709. PubMed ID: 23451715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Riboflavin-ultraviolet light pathogen reduction treatment does not impact the immunogenicity of murine red blood cells.
    Tormey CA; Santhanakrishnan M; Smith NH; Liu J; Marschner S; Goodrich RP; Hendrickson JE
    Transfusion; 2016 Apr; 56(4):863-72. PubMed ID: 26643781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and development of a method for the reduction of infectious pathogen load and inactivation of white blood cells in whole blood products.
    Goodrich RP; Doane S; Reddy HL
    Biologicals; 2010 Jan; 38(1):20-30. PubMed ID: 20093041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.